ribavirin has been researched along with Rheumatoid Arthritis in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Bair, MJ; Chen, CJ; Chen, CY; Chen, JJ; Cheng, JS; Cheng, PN; Chien, RN; Chiu, YC; Chu, CH; Chuang, WL; Dai, CY; Hsu, WF; Huang, JF; Huang, YH; Hung, CH; Kao, JH; Kuo, HT; Lai, HC; Lee, PL; Lin, CW; Lin, CY; Lin, HC; Liu, CH; Liu, CJ; Lo, CC; Lo, GH; Peng, CY; Su, WW; Tai, CM; Tsai, PC; Tsai, WL; Tseng, KC; Tung, SY; Wang, CC; Wang, JH; Yan, SL; Yang, CC; Yu, ML | 1 |
| Benanti, F; Cacopardo, B; Nunnari, G; Pinzone, MR | 1 |
| Dollenmaier, G; Krayenbühl, PA; Mani, B; Sahli, R; Schultze, D; Zbinden, A | 1 |
| Di Martino, V; Prati, C; Thevenot, T; Verhoeven, F; Weil-Verhoeven, D; Wendling, D | 1 |
| Ledeboer, M; Martens, HA; van Bijnen, ST | 1 |
| Abiru, S; Hashimoto, S; Ishibashi, H; Izumi, Y; Komori, A; Migita, K; Miyashita, T; Yasunaga, Y; Yatsuhashi, H | 1 |
| Anty, R; Euller-Ziegler, L; Patouraux, S; Roux, CH | 1 |
| Gibofsky, A; Niewold, TB | 1 |
8 other study(ies) available for ribavirin and Rheumatoid Arthritis
| Article | Year |
|---|---|
Sustained virological response to hepatitis C therapy does not decrease the incidence of systemic lupus erythematosus or rheumatoid arthritis.
Topics: Adult; Antiviral Agents; Arthritis, Rheumatoid; Autoimmune Diseases; Cohort Studies; Drug Therapy, Combination; Female; Hepatitis C; Hepatitis C, Chronic; Humans; Incidence; Interferon-alpha; Lupus Erythematosus, Systemic; Male; Middle Aged; Polyethylene Glycols; Proportional Hazards Models; Ribavirin; Sustained Virologic Response; Taiwan; Viral Load | 2020 |
Rheumatoid arthritis following PEG-interferon-alfa-2a plus ribavirin treatment for chronic hepatitis C: a case report and review of the literature.
Topics: Antiviral Agents; Arthritis, Rheumatoid; Autoantibodies; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Peptides, Cyclic; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome | 2013 |
Acute Hepatitis E Virus infection with coincident reactivation of Epstein-Barr virus infection in an immunosuppressed patient with rheumatoid arthritis: a case report.
Topics: Aged; Arthritis, Rheumatoid; Coinfection; Epstein-Barr Virus Infections; Female; Hepatitis Antibodies; Hepatitis B virus; Hepatitis E; Herpesvirus 4, Human; Humans; Immunocompromised Host; Immunosuppressive Agents; Ribavirin | 2015 |
Management of acute HVE infection in a patient treated with rituximab for rheumatoid arthritis.
Topics: Acute Disease; Antirheumatic Agents; Antiviral Agents; Arthritis, Rheumatoid; Female; Hepatitis E; Humans; Immunocompromised Host; Middle Aged; Ribavirin; Rituximab | 2016 |
Chronic hepatitis E in a patient with rheumatoid arthritis treated with adalimumab and methotrexate.
Topics: Adalimumab; Antirheumatic Agents; Antiviral Agents; Arthritis, Rheumatoid; Hepatitis E; Hepatitis, Chronic; Humans; Immunocompromised Host; Male; Methotrexate; Middle Aged; Ribavirin | 2017 |
Rheumatoid arthritis following a treatment with IFN-alpha/ribavirin against HCV infection.
Topics: Antiviral Agents; Arthritis, Rheumatoid; Autoantibodies; B-Cell Activating Factor; Cytokines; Hepatitis C, Chronic; Humans; Interferon Type I; Magnetic Resonance Imaging; Male; Middle Aged; Peptides, Cyclic; Recombinant Proteins; Ribavirin; Risk Factors | 2011 |
Hepatitis E: are rheumatic patients at risk?
Topics: Antiviral Agents; Arthritis, Rheumatoid; Hepatitis E; Humans; Male; Middle Aged; Ribavirin; Risk Factors; Treatment Outcome | 2013 |
Concomitant interferon-alpha therapy and tumor necrosis factor alpha inhibition for rheumatoid arthritis and hepatitis C.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Etanercept; Hepatitis C; Humans; Immunoglobulin G; Interferon-alpha; Male; Middle Aged; Receptors, Tumor Necrosis Factor; Ribavirin; Tumor Necrosis Factor-alpha | 2006 |